Obesity Trial, Recruiting NCT07672821 Sponsor: Medipol University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07672821
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years old who are living with obesity and have not had weight loss (bariatric) surgery
  • Adults between 18 and 65 years old who are living with obesity, have had weight loss (bariatric) surgery, and lost less than a certain amount of weight within 18 months after the surgery (specifically, less than 50% of their excess weight lost, as calculated by the trial team)
  • Adults between 18 and 65 years old who are living with obesity, have had weight loss (bariatric) surgery, and have regained a significant portion of the weight they had previously lost (specifically, more than a 25% increase from their lowest recorded weight, as calculated by the trial team)

Who may not be able to join:

  • People who are currently pregnant or breastfeeding
  • People who have an acute illness, an active infection, or certain other health conditions that could affect the safety or effectiveness of the treatment — this includes cancer, type 1 diabetes, kidney or liver failure, a recent stroke or heart attack, kidney stones, drug or alcohol misuse, eating disorders, severe depression or other mental health conditions, inflammatory bowel disease, certain tumours, heart rhythm problems, heart failure, respiratory failure, or those currently taking corticosteroid medications
  • People who are professional athletes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905393919700

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medipol University
Registry
ClinicalTrials.gov
Start date
12 July 2025
Est. completion
1 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Body Weight; Body Mass Index (BMI); Body Fat Mass; Muscle Mass; Waist Circumference; Hip Circumference; Percentage of Excess Weight Loss (%EWL); Percentage of Total Weight Loss (%TWL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov